Cargando…
Metastatic medullary thyroid carcinoma: a new way forward
Medullary thyroid carcinoma (MTC) is a rare malignancy comprising 1–2% of all thyroid cancers in the United States. Approximately 20% of cases are familial, secondary to a germline RET mutation, while the remaining 80% are sporadic and also harbour a somatic RET mutation in more than half of all cas...
Autores principales: | Angelousi, Anna, Hayes, Aimee R, Chatzellis, Eleftherios, Kaltsas, Gregory A, Grossman, Ashley B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175549/ https://www.ncbi.nlm.nih.gov/pubmed/35521769 http://dx.doi.org/10.1530/ERC-21-0368 |
Ejemplares similares
-
Pancreatic carcinoids (serotonin-producing pancreatic neuroendocrine neoplasms): Report of 5 cases and review of the literature
por: Tsoukalas, Nikolaos, et al.
Publicado: (2017) -
Current best practice in the management of neuroendocrine
tumors
por: Tsoli, Marina, et al.
Publicado: (2018) -
Medullary Thyroid Carcinoma Presenting as Metastatic Disease to the Breast
por: Kanteti, Archana P., et al.
Publicado: (2020) -
Cabozantinib for the Treatment of Metastatic Medullary Thyroid Carcinoma
por: Nix, Nancy M., et al.
Publicado: (2014) -
Metastatic medullary thyroid carcinoma: A case report
por: Niafar, Mitra, et al.
Publicado: (2011)